Language of Resource
Full Text Available
Open Access / OK to Reproduce
We examined whether rurality, social inequity, and racialized segregation across communities from four states in the HEALing Communities Study (HCS) were associated with 1) greater perceived community stigma toward people treated for opioid use disorder (OUD), 2) greater perceived intervention stigma toward medications for opioid use disorder (MOUD), and 3) greater perceived intervention stigma toward naloxone by community stakeholders in the HEALing Communities Study (HCS).
On average, the perceived community OUD stigma scale score of stakeholders from rural communities was 4% higher, stigma toward MOUD was 6% higher, and stigma toward naloxone was 10% higher than among stakeholders from urban communities. No significant differences in the three stigma variables were found among communities based on racialized segregation or social inequity.
Cross-sectional survey (n=801)